MedTrace Logo

Anti-Müllerian Hormone and Embryo Aneuploidy

NCT05723016 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-02-10

No results posted yet for this study

Summary

The goal of this observational study is to determine is there an association between the rates of aneuploidy and the different ranges of serum Antimullerian hormone (AMH) levels.

Retrospective, single-centre study of patients undergoing IVF and preimplantation genetic testing with aneuploidy at the blastocyst stage between January 2018 and December 2022.

Conditions

Interventions

OTHER

preimplantation genetic test for aneuploidies (PGT-a)

preimplantation genetic test for embryo aneuploidies after IVF

Sponsors & Collaborators

  • Clinica de la Mujer Medicina Reproductiva, Chile

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Chile

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05723016 on ClinicalTrials.gov